Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacovigilance of Bio-Manguinhos Interferon alfa-2b in Hepatitis C Genotypes 2/3
NCT01841775Phase 4Completed
- Sponsor
- Immunobiological Technology Institute
- Start
- May 2009
- Primary completion
- Sep 2012
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of Interferon alfa-2b vaginal effervescent tablet in hepatitis C (HCV), sponsored by Immunobiological Technology Institute. Started May 2009; status: completed.
02
Drugs
Interferon alfa-2b vaginal effervescent tablet
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01841775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01841775.